DUSP4/MKP2 overexpression is associated with BRAF(V600E) mutation and aggressive behavior of papillary thyroid cancer

The study was performed to retrospectively analyze the correlation of dual specificity phosphatase 4 (DUSP4) expression with clinicopathological variables and BRAF(V600E) mutation to better characterize the potential role of DUSP4 as a biomarker in papillary thyroid cancer (PTC). Patients (n=120) wh...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Onco Targets Ther
Päätekijät: Ma, Ben, Shi, Rongliang, Yang, Shuwen, Zhou, Li, Qu, Ning, Liao, Tian, Wang, Yu, Wang, Yulong, Ji, Qinghai
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2016
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4844429/
https://ncbi.nlm.nih.gov/pubmed/27143921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S103554
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia